159 related articles for article (PubMed ID: 38243085)
1. Radiation-induced changes in gene expression in rectal cancer specimens.
Hillson LVS; McCulloch AK; Edwards J; Dunne PD; O'Cathail SM; Roxburgh CS
Clin Transl Oncol; 2024 Jun; 26(6):1419-1428. PubMed ID: 38243085
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemoradiation alters biomarkers of anticancer immunotherapy responses in locally advanced rectal cancer.
Seo I; Lee HW; Byun SJ; Park JY; Min H; Lee SH; Lee JS; Kim S; Bae SU
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33692216
[TBL] [Abstract][Full Text] [Related]
3. Differential and longitudinal immune gene patterns associated with reprogrammed microenvironment and viral mimicry in response to neoadjuvant radiotherapy in rectal cancer.
Wilkins A; Fontana E; Nyamundanda G; Ragulan C; Patil Y; Mansfield D; Kingston J; Errington-Mais F; Bottomley D; von Loga K; Bye H; Carter P; Tinkler-Hundal E; Noshirwani A; Downs J; Dillon M; Demaria S; Sebag-Montefiore D; Harrington K; West N; Melcher A; Sadanandam A
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33678606
[TBL] [Abstract][Full Text] [Related]
4. Global DNA methylation is altered by neoadjuvant chemoradiotherapy in rectal cancer and may predict response to treatment - A pilot study.
Tsang JS; Vencken S; Sharaf O; Leen E; Kay EW; McNamara DA; Deasy J; Mulligan ED
Eur J Surg Oncol; 2014 Nov; 40(11):1459-66. PubMed ID: 25108814
[TBL] [Abstract][Full Text] [Related]
5. Does chronomodulated radiotherapy improve pathological response in locally advanced rectal cancer?
Squire T; Buchanan G; Rangiah D; Davis I; Yip D; Chua YJ; Rich T; Elsaleh H
Chronobiol Int; 2017; 34(4):492-503. PubMed ID: 28353363
[TBL] [Abstract][Full Text] [Related]
6. Early dynamic transcriptomic changes during preoperative radiotherapy in patients with rectal cancer: a feasibility study.
Supiot S; Gouraud W; Campion L; Jezéquel P; Buecher B; Charrier J; Heymann MF; Mahé MA; Rio E; Chérel M
World J Gastroenterol; 2013 Jun; 19(21):3249-54. PubMed ID: 23745026
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients.
Svoboda M; Sana J; Fabian P; Kocakova I; Gombosova J; Nekvindova J; Radova L; Vyzula R; Slaby O
Radiat Oncol; 2012 Nov; 7():195. PubMed ID: 23167930
[TBL] [Abstract][Full Text] [Related]
8. YKL-40/c-Met expression in rectal cancer biopsies predicts tumor regression following neoadjuvant chemoradiotherapy: a multi-institutional study.
Senetta R; Duregon E; Sonetto C; Spadi R; Mistrangelo M; Racca P; Chiusa L; Munoz FH; Ricardi U; Arezzo A; Cassenti A; Castellano I; Papotti M; Morino M; Risio M; Cassoni P
PLoS One; 2015; 10(4):e0123759. PubMed ID: 25875173
[TBL] [Abstract][Full Text] [Related]
9. Wnt-signaling and apoptosis after neoadjuvant short-term radiotherapy for rectal cancer.
Gassler N; Herr I; Keith M; Autschbach F; Schmitz-Winnenthal H; Ulrich A; Otto HF; Kartenbeck J; Z'graggen K
Int J Oncol; 2004 Dec; 25(6):1543-9. PubMed ID: 15547689
[TBL] [Abstract][Full Text] [Related]
10. Effect of preoperative radiotherapy on matrilysin gene expression in rectal cancer.
Kumar A; Collins H; Van Tam J; Scholefield JH; Watson SA
Eur J Cancer; 2002 Mar; 38(4):505-10. PubMed ID: 11872342
[TBL] [Abstract][Full Text] [Related]
11. Thymidylate synthase genotype-directed neoadjuvant chemoradiation for patients with rectal adenocarcinoma.
Tan BR; Thomas F; Myerson RJ; Zehnbauer B; Trinkaus K; Malyapa RS; Mutch MG; Abbey EE; Alyasiry A; Fleshman JW; McLeod HL
J Clin Oncol; 2011 Mar; 29(7):875-83. PubMed ID: 21205745
[TBL] [Abstract][Full Text] [Related]
12. Identification of a biomarker profile associated with resistance to neoadjuvant chemoradiation therapy in rectal cancer.
Garcia-Aguilar J; Chen Z; Smith DD; Li W; Madoff RD; Cataldo P; Marcet J; Pastor C
Ann Surg; 2011 Sep; 254(3):486-92; discussion 492-3. PubMed ID: 21865946
[TBL] [Abstract][Full Text] [Related]
13. Temporal determinants of tumour response to neoadjuvant rectal radiotherapy.
Koo K; Ward R; Smith RL; Ruben J; Carne PWG; Elsaleh H
PLoS One; 2021; 16(6):e0254018. PubMed ID: 34191861
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment transcriptional profiling for predicting response to neoadjuvant chemoradiotherapy in rectal adenocarcinoma.
Brettingham-Moore KH; Duong CP; Greenawalt DM; Heriot AG; Ellul J; Dow CA; Murray WK; Hicks RJ; Tjandra J; Chao M; Bui A; Joon DL; Thomas RJ; Phillips WA
Clin Cancer Res; 2011 May; 17(9):3039-47. PubMed ID: 21224373
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety-in analysis of short-course radiation followed by mFOLFOX-6 plus avelumab for locally advanced rectal adenocarcinoma.
Shamseddine A; Zeidan YH; El Husseini Z; Kreidieh M; Al Darazi M; Turfa R; Kattan J; Khalifeh I; Mukherji D; Temraz S; Alqasem K; Amarin R; Al Awabdeh T; Deeba S; Jamali F; Mohamad I; Elkhaldi M; Daoud F; Al Masri M; Dabous A; Hushki A; Jaber O; Charafeddine M; Geara F
Radiat Oncol; 2020 Oct; 15(1):233. PubMed ID: 33028346
[TBL] [Abstract][Full Text] [Related]
16. Intensity-Modulated Radiation Therapy Is Not Associated with Perioperative or Survival Benefit over 3D-Conformal Radiotherapy for Rectal Cancer.
Sun Z; Adam MA; Kim J; Czito B; Mantyh C; Migaly J
J Gastrointest Surg; 2017 Jan; 21(1):106-111. PubMed ID: 27510332
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor receptor-1 overexpression is associated with poor response of rectal cancers to radiotherapy.
Wu XY; Wu ZF; Cao QH; Chen C; Chen ZW; Xu Z; Li WS; Liu FK; Yao XQ; Li G
World J Gastroenterol; 2014 Nov; 20(43):16268-74. PubMed ID: 25473182
[TBL] [Abstract][Full Text] [Related]
18. Abdominoperineal resection for rectal cancer at a specialty center.
Nissan A; Guillem JG; Paty PB; Douglas Wong W; Minsky B; Saltz L; Cohen AM
Dis Colon Rectum; 2001 Jan; 44(1):27-35; discussion 35-6. PubMed ID: 11805560
[TBL] [Abstract][Full Text] [Related]
19. Short-term preoperative radiotherapy is a safe approach for treatment of locally advanced rectal cancer.
Korkolis DP; Plataniotis GD; Gondikakis E; Xinopoulos D; Koulaxouzidis GV; Katsilieris J; Vassilopoulos PP
Int J Colorectal Dis; 2006 Jan; 21(1):1-6. PubMed ID: 15947936
[TBL] [Abstract][Full Text] [Related]
20. Phase II and gene expression analysis trial of neoadjuvant capecitabine plus irinotecan followed by capecitabine-based chemoradiotherapy for locally advanced rectal cancer: Hoosier Oncology Group GI03-53.
Chiorean EG; Sanghani S; Schiel MA; Yu M; Burns M; Tong Y; Hinkle DT; Coleman N; Robb B; LeBlanc J; Clark R; Bufill J; Curie C; Loehrer PJ; Cardenes H
Cancer Chemother Pharmacol; 2012 Jul; 70(1):25-32. PubMed ID: 22610353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
